Data from Multiple Clinical Trials of OrbusNeich's Genous™ Bio-engineered R Stent™ Demonstrate Safety and Effectiveness Across Challenging Patient Subsets as Presented a... (ces such as stents. The technology consi...)

HOME >> MEDICINE >> TECHNOLOGY

Data from Multiple Clinical Trials of OrbusNeich's Genous™ Bio-engineered R Stent™ Demonstrate Safety and Effectiveness Across Challenging Patient Subsets as Presented at TCT 2010

Date:9/25/2010

ces such as stents. The technology consists of an antibody surface coating that attracts EPCs circulating in the blood to the device to form an endothelial layer that provides protection against thrombosis and modulates restenosis.

OrbusNeich's Genous Bio-engineered R stent has been commercially available in over 60 countries since 2005. The Genous stent has been proven as a safe, effective alternative to drug-eluting stents and is supported by data from more than 5,000 patients in company-sponsored clinical studies. There is a growing body of evidence from multiple clinical studies that the Genous stent is effective for patients who are non-responsive to or cannot tolerate long-term dual antiplatelet therapy.

About OrbusNeich

OrbusNeich is a global company that designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. Current products are the world's first pro-healing stent, the Genous Bio-engineered R stent, as well as stents, balloons and guiding catheters marketed under the names of Blazer™, R stent, Scoreflex™, Sapphire™ and Sapphire NC. Development stage products include the Combo Bio-engineered Sirolimus Eluting Stent, or Combo Stent, which combines the Genous pro-healing technology for rapid endothelial coverage with an abluminal sirolimus drug elution for the control of neointimal proliferation. OrbusNeich is headquartered in Hong Kong and has operations in Shenzhen, China; Fort Lauderdale, Fla.; Hoevelaken, The Netherlands; and Tokyo, Japan. OrbusNeich, which has provided medical devices to physicians through its predecessor companies since 1979, supplies products today to interventional cardiologists in more than 60 countries. For more information, visit www.OrbusNeich.com.

SOURCE OrbusNeich
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
3. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
4. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
5. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
6. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
7. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
8. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
9. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
10. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
11. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease

Post Your Comments:

(Date:5/24/2013)... Solta Medical, Inc. (NASDAQ: SLTM ), ... Dr. Edward W. Knowlton has resigned ... immediately. Dr. Knowlton is the founder of Thermage, the predecessor ... since 1996. "On behalf of the entire Board ... like to thank Ed for his tireless dedication to our ...

(Date:5/24/2013)... , May 24, 2013 In accordance with ... and Rule 14e-1 of the United States Exchange Act, Echo ... original offer for Elan Corporation (NYSE: ELN). Background ... ("Royalty Pharma") made an offer for the entire of the ... plc ("Elan") (the "Original Offer"). On 20 ...

(Date:5/23/2013)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ) ... Life Science Firm of the Year by the Tech Council ... at the TCM,s 25 th Annual Tech Awards Celebration ... Awards Celebration recognizes the leaders and innovators in the technology ... and the surrounding regions. "We are deeply ...

[0] Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.[0] Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements [0] Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland

... is developing and testing innovative HIV/AIDS vaccines, has engaged The Investor Relations Group ("IRG"), a thirteen-year-old, award-winning, corporate communications firm based in ... ... , , ... ...

... DALLAS , March 22 Texas Instruments ... first in a family of fully integrated analog front ends ... electroencephalogram (EEG) equipment, as well as patient monitoring and consumer ... count and power consumption by up to 95 percent as ...

Cached Medicine Technology:GeoVax Labs Engages The Investor Relations Group 2 GeoVax Labs Engages The Investor Relations Group 3 GeoVax Labs Engages The Investor Relations Group 4 Texas Instruments unveils fully integrated analog front end for ECG and EEG applications 2 Texas Instruments unveils fully integrated analog front end for ECG and EEG applications 3 Texas Instruments unveils fully integrated analog front end for ECG and EEG applications 4 Texas Instruments unveils fully integrated analog front end for ECG and EEG applications 5 Texas Instruments unveils fully integrated analog front end for ECG and EEG applications 6 Texas Instruments unveils fully integrated analog front end for ECG and EEG applications 7

GeoVax Labs Engages The Investor Relations Group Texas Instruments unveils fully integrated analog front end for ECG and EEG applications

(Date:5/25/2013)... May 25, 2013 For college ... finals week. Increasingly, they are turning to prescription ... and study. For more on this, go to ... treatment facility, warns that students who pick up ... at risk for developing a physical and psychological ...

(Date:5/25/2013)... 2013 Ayurveda is the traditional ... or wisdom of life". While a medical science, its scope ... of consciousness. Its fundamental philosophy is that disease is the ... It believes that in order to re-establish optimal health, we ... then adopt a life style which brings us back into ...

(Date:5/25/2013)... 2013 The current residents of Back2Basics - ... the B2B staff all came together Saturday, May 18th to ... of Indian Cuisine, the residents got up to thank Roy ... on their road to recovery, and giving them a second ... center in 2010 after realizing the need for a long-term ...

(Date:5/25/2013)... 25, 2013 http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html , ... judge's overturning of a jury's award of $6.5 million ... trial* in the country over allegations that the diabetes ... files. , The judge in the case ruled that ... his cancer was caused by the medication.** , Bloomberg ...

(Date:5/25/2013)... 2013 AdvantaClean of Pikes Peak recently ... for a healthy home and business in Colorado Springs ... , mold inspections, mold testing, mold removal , ... coil cleaning. , With over 120 offices nationwide, AdvantaClean ... offering a full suite of services for commercial, institutional, ...

Breaking Medicine News(10 mins):Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2 Health News:Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes 2 Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2 Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 2 Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 3 Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 4 Health News:Grand Opening! AdvantaClean of Pikes Peak is Proud to Announce Water Damage Restoration, Mold Removal and Air Duct Cleaning Services to the Colorado Springs Area 2 Health News:Grand Opening! AdvantaClean of Pikes Peak is Proud to Announce Water Damage Restoration, Mold Removal and Air Duct Cleaning Services to the Colorado Springs Area 3 Health News:Grand Opening! AdvantaClean of Pikes Peak is Proud to Announce Water Damage Restoration, Mold Removal and Air Duct Cleaning Services to the Colorado Springs Area 4

[0] Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals [0] Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes [0] Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary [0] Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases [0] Grand Opening! AdvantaClean of Pikes Peak is Proud to Announce Water Damage Restoration, Mold Removal and Air Duct Cleaning Services to the Colorado Springs Area

... diabetes found in mice could open the door to exploring ... System research has found. Drugs for type 2 diabetes ... U-M study suggests that glucagon a pancreas-produced hormone that ... levels may also provide a powerful pathway to preventing ...

... editors of Gastroenterology , the official journal of ... announce the publication of this year,s highly anticipated special ... devoted to a particular gastroenterological topic of broad interest; ... conjunction with editor-in-chief M. Bishr Omary, MD, PhD, this ...

... Maureen Salamon HealthDay Reporter , MONDAY, May 14 ... often played for drama or laughs, but the phenomenon is ... In what they said is the first research in ... from Stanford University School of Medicine found that about 3.6 ...

... A new national initiative promises to improve college biology ... change how post-secondary life sciences departments approach education. ... Education, is a collaborative effort funded by the National ... the Howard Hughes Medical Institute (HHMI). Program organizers ...

... ,Communities of Solution, to Address Today,s Fragmented U.S. Health ... to reform the U.S. health care system, a group ... of community-centered health systems, as originally outlined in the ... the original Folsom commission could not be more pertinent ...

... MONDAY, May 14 (HealthDay News) -- People with HIV/AIDS are ... than those in the general population, a new study finds. ... HIV, according to researchers from the University of California, San ... sudden cardiac death, the heart suddenly and unexpectedly stops beating. ...

Cached Medicine News:Health News:New inflammation hormone link may pave way to study new drugs for Type 2 diabetes 2 Health News:Gastroenterology special issue focuses on new directions of viral hepatitis care and research 2 Health News:Gastroenterology special issue focuses on new directions of viral hepatitis care and research 3 Health News:Sleepwalking in Adults More Common Than Thought 2 Health News:Sleepwalking in Adults More Common Than Thought 3 Health News:National initiative launched to change the way biology departments approach undergraduate education 2 Health News:National initiative launched to change the way biology departments approach undergraduate education 3 Health News:May/June 2012 Annals of Family Medicine tip sheet 2 Health News:May/June 2012 Annals of Family Medicine tip sheet 3 Health News:May/June 2012 Annals of Family Medicine tip sheet 4 Health News:May/June 2012 Annals of Family Medicine tip sheet 5 Health News:May/June 2012 Annals of Family Medicine tip sheet 6 Health News:May/June 2012 Annals of Family Medicine tip sheet 7 Health News:May/June 2012 Annals of Family Medicine tip sheet 8 Health News:People With HIV at Higher Odds of Sudden Cardiac Death 2

New inflammation hormone link may pave way to study new drugs for Type 2 diabetes Gastroenterology special issue focuses on new directions of viral hepatitis care and research Sleepwalking in Adults More Common Than Thought National initiative launched to change the way biology departments approach undergraduate education May/June 2012 Annals of Family Medicine tip sheet People With HIV at Higher Odds of Sudden Cardiac Death

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

Medicine Products:

Lymphocyte Subset Panel 6-Total Lymphocyte Enumeration with CD45RA & CD45RO Lymphocyte Subset Panel 4-T-Cell Subsets Percent & Absolute Lymphocyte Subset Panel 3-T-Cell Subsets (CD4 & CD8), Absolute Counts Only Lymphocyte Subset Panel 2-CD4 Percent & Absolute